Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion type Assertion NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_head.
- NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion description "[Results showed that the mutant rES-CSP reduce the stability and loss of function, and the wild-type rES-CSP could both bind to the normal liver cells Chang's and the hepatoma cells HepG2 but significantly higher than non-targeted rEndostatin. rESCSP could inhibit the proliferation of hepatoma cells in a dose-dependent manner, and increase the proportion of G1 phase, reduce the proportion of S phase, promote the apoptosis on hepatoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_provenance.
- NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion evidence source_evidence_literature NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_provenance.
- NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion SIO_000772 25731590 NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_provenance.
- NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion wasDerivedFrom befree-2016 NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_provenance.
- NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_assertion wasGeneratedBy ECO_0000203 NP1267465.RAyIimp4Gj_915spHFWmJsagLBkXKtP6O9a9Eh2v5kab8130_provenance.